Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9015 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8855 |
High Similarity |
NPD943 |
Approved |
0.8768 |
High Similarity |
NPD7390 |
Discontinued |
0.873 |
High Similarity |
NPD1201 |
Approved |
0.8571 |
High Similarity |
NPD1240 |
Approved |
0.8462 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8456 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8444 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8321 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8273 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8261 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8261 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8261 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8254 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8071 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD1164 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7902 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7872 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7808 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7808 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7727 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7705 |
Intermediate Similarity |
NPD940 |
Approved |
0.7705 |
Intermediate Similarity |
NPD846 |
Approved |
0.7698 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7623 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7619 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7619 |
Intermediate Similarity |
NPD74 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7597 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7556 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD9264 |
Approved |
0.754 |
Intermediate Similarity |
NPD9267 |
Approved |
0.754 |
Intermediate Similarity |
NPD9263 |
Approved |
0.754 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD9545 |
Approved |
0.731 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7295 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7295 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7472 |
Approved |
0.723 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7213 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7213 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7183 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7154 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7154 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7132 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD1755 |
Approved |
0.7121 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7016 |
Intermediate Similarity |
NPD844 |
Approved |
0.7015 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7013 |
Intermediate Similarity |
NPD920 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.6993 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.698 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD422 |
Phase 1 |
0.697 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD6663 |
Approved |
0.696 |
Remote Similarity |
NPD288 |
Approved |
0.6957 |
Remote Similarity |
NPD17 |
Approved |
0.6957 |
Remote Similarity |
NPD4626 |
Approved |
0.6935 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5736 |
Approved |
0.6918 |
Remote Similarity |
NPD2296 |
Approved |
0.6918 |
Remote Similarity |
NPD4288 |
Approved |
0.6899 |
Remote Similarity |
NPD1237 |
Approved |
0.6897 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD411 |
Approved |
0.6894 |
Remote Similarity |
NPD919 |
Approved |
0.6893 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD5401 |
Approved |
0.6879 |
Remote Similarity |
NPD4749 |
Approved |
0.6879 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD447 |
Suspended |
0.6871 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD1281 |
Approved |
0.6846 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6842 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6828 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6822 |
Remote Similarity |
NPD1929 |
Approved |
0.6822 |
Remote Similarity |
NPD1930 |
Approved |
0.6822 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6815 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD3091 |
Approved |
0.6812 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.681 |
Remote Similarity |
NPD1247 |
Approved |
0.681 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6809 |
Remote Similarity |
NPD4878 |
Approved |
0.6806 |
Remote Similarity |
NPD9494 |
Approved |
0.6797 |
Remote Similarity |
NPD6190 |
Approved |
0.6792 |
Remote Similarity |
NPD37 |
Approved |
0.6786 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD3266 |
Approved |
0.6783
|
Remote Similarity |
NPD3267 |
Approved |